20/01/2022 - 15:00

Euroz backs Australian pharma

20/01/2022 - 15:00

Bookmark

Save articles for future reference.

A pharmaceutical company specialising in the treatment of common colds and viral diseases will list on the ASX this month, having raised $7 million through an IPO.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options